Select Search Option
Weill Cornell Medicine
Menu
  • Care
  • Discover
  • Teach
  • Departments
  • WCM
  • About
    • About EIPM
    • Mission
    • Glossary
    • Career Opportunities
    • Support Precision Medicine
    • FAQ
  • Team
    • EIPM Team
    • Partnerships
      • All of Us
      • NYGC
      • cBioPortal
      • EuroPDX
  • News
    • EIPM News
    • Events
  • Care
    • Precision Medicine Care
    • Patient Care
    • Clinicians
    • Clinical Genomic Tests
  • Research
    • EIPM Research
    • Publications
    • Innovation Lab
      • Organoids
      • Non Clinical Assays
        • PreCISE a deep sequencing test for CH and major germline alleles
    • Disease Areas
    • Computational Biomedicine
      • Spatial Computing
        • Oculome
        • Holo Graph
        • DropSeq
        • mrLab
      • AI
        • Precision Medicine Knowledgebase Bot
    • Drug Discovery
    • Molecular Aging Initiative
  • Teach
    • EIPM Education
    • EIPM Internship Program
    • Area of Concentration
    • Tumor Boards
  • Resources
    • Precision Medicine Knowledgebase
    • Preclinical Pharmacy
    • Mass Cytometry
  • Contact
    • Contact Form
Close
  • About
    • About EIPM
    • Mission
    • Glossary
    • Career Opportunities
    • Support Precision Medicine
    • FAQ
  • Team
    • EIPM Team
    • Partnerships
      • All of Us
      • NYGC
      • cBioPortal
      • EuroPDX
  • News
    • EIPM News
    • Events
  • Care
    • Precision Medicine Care
    • Patient Care
    • Clinicians
    • Clinical Genomic Tests
  • Research
    • EIPM Research
    • Publications
    • Innovation Lab
      • Organoids
      • Non Clinical Assays
        • PreCISE a deep sequencing test for CH and major germline alleles
    • Disease Areas
    • Computational Biomedicine
      • Spatial Computing
        • Oculome
        • Holo Graph
        • DropSeq
        • mrLab
      • AI
        • Precision Medicine Knowledgebase Bot
    • Drug Discovery
    • Molecular Aging Initiative
  • Teach
    • EIPM Education
    • EIPM Internship Program
    • Area of Concentration
    • Tumor Boards
  • Resources
    • Precision Medicine Knowledgebase
    • Preclinical Pharmacy
    • Mass Cytometry
  • Contact
    • Contact Form

Tag: News from WCM

HomeNewsTag: News from WCM
Adding Epigenetic Drug Was Effective in Pilot Study for PTCL-TFH

Adding Epigenetic Drug Was Effective in Pilot Study for PTCL-TFH

May 5, 2023 165 1

Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell...

Read more
Obesity May Exacerbate Breast Cancer Risk in Women with BRCA Mutations

Obesity May Exacerbate Breast Cancer Risk in Women with BRCA Mutations

March 10, 2023 157 1

Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by...

Read more
EIPM Researcher Awarded Grant from Starr Cancer Consortium

EIPM Researcher Awarded Grant from Starr Cancer Consortium

February 11, 2023 444 1

Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th annual grant competition. The grants will fund research on the molecular origins and evolution of blood, bladder, breast...

Read more
EIPM Researchers Find Enzyme That Protects Against Viruses Could Fuel Cancer Evolution

EIPM Researchers Find Enzyme That Protects Against Viruses Could Fuel Cancer Evolution

December 28, 2022 440 6

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests...

Read more
EIPM Harnessing Artificial Intelligence Technology for IVF Embryo Selection

EIPM Harnessing Artificial Intelligence Technology for IVF Embryo Selection

December 21, 2022 470 9

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell...

Read more
EIPM Researcher: To Trigger Crohn’s Disease, Pathogenic Bacteria Co-opt a Genetic Susceptibility

EIPM Researcher: To Trigger Crohn’s Disease, Pathogenic Bacteria Co-opt a Genetic Susceptibility

December 6, 2022 386 11

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. These findings could one day...

Read more
NIH Grant Funds Cancer Prevention Vaccine Research

NIH Grant Funds Cancer Prevention Vaccine Research

November 11, 2022 422 8

A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines...

Read more
EIPM Researcher: Gene Duo Protects Blood Vessel Health

EIPM Researcher: Gene Duo Protects Blood Vessel Health

October 7, 2022 547 12

Two genes working in concert sustain the integrity of healthy blood vessels, Weill Cornell Medicine investigators discovered in new research. The findings could lead to new approaches treating cardiovascular disease or other inflammatory...

Read more
Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

September 5, 2022 530 2

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from...

Read more
Researchers Identify the Target of Immune Attacks on Liver Cells

Researchers Identify the Target of Immune Attacks on Liver Cells

August 19, 2022 735 6

Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that...

Read more
New Cancer Subtype May Illuminate Treatment Strategy

New Cancer Subtype May Illuminate Treatment Strategy

May 27, 2022 715 3

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery...

Read more
EIPM Member Inducted into Association of American Physicians

EIPM Member Inducted into Association of American Physicians

April 11, 2022 726 7

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the esteemed Association of American Physicians (AAP). Regarded as one of the top honors in the...

Read more
12
Our Location
Caryl and Israel Englander
Institute for Precision Medicine
Contact Us
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
413 E 69th Street
Belfer Research Building
New York, NY 10021
  • About +
  • Patients +
  • Clinicians +
  • News +
  • Innovation Lab +
  • Education +
  • Contact +
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
Forgot password?
You can login using your social profile
Problem with login?